Key result
CRT yields comparable functional improvements and procedural safety in elderly versus younger heart failure patients.
Why the study?
Elderly patients are under-represented in clinical trials evaluating the efficacy and safety of CRT and ICD, with confounding factors leading to their exclusion.
No takes yet. Share an insight, caveat, or question.
May support CRT consideration in elderly HF patients; leaves open randomized confirmation.
Vetta et al. (2019) conducted a review in Heart failure. Cardiac resynchronization therapy (CRT) was evaluated. Cardiac resynchronization therapy provides comparable functional and morphological improvements in elderly patients with heart failure as in younger patients, without significant age-related differences in procedural safety.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: